STERIS Plc Financials

STE Stock  USD 216.12  1.78  0.83%   
Based on the measurements of operating efficiency obtained from STERIS Plc's historical financial statements, STERIS plc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, STERIS Plc's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 502 M, whereas Cash And Short Term Investments are forecasted to decline to about 126.3 M. Key indicators impacting STERIS Plc's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.06170.0736
Fairly Down
Pretty Stable
Return On Assets0.03250.0342
Notably Down
Slightly volatile
Return On Equity0.110.06
Way Up
Slightly volatile
Debt Equity Ratio0.450.5087
Fairly Down
Very volatile
Operating Income877.9 M836.1 M
Sufficiently Up
Slightly volatile
Current Ratio2.863.0813
Significantly Down
Slightly volatile
The essential information of the day-to-day investment outlook for STERIS Plc includes many different criteria found on its balance sheet. An individual investor should monitor STERIS Plc's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in STERIS Plc.

Cash And Equivalents

283.15 Million

  
Understanding current and past STERIS Plc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of STERIS Plc's financial statements are interrelated, with each one affecting the others. For example, an increase in STERIS Plc's assets may result in an increase in income on the income statement.

STERIS Plc Earnings Geography

Please note, the presentation of STERIS Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STERIS Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STERIS Plc's management manipulating its earnings.

STERIS Plc Stock Summary

STERIS Plc competes with Orthofix Medical, Glaukos Corp, Bruker, CONMED, and Anika Therapeutics. STERIS plc provides infection prevention and other procedural products and services worldwide. The company was founded in 1985 and is based in Dublin, Ireland. Steris Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 16000 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINIE00BFY8C754
CUSIPG8473T100 G84720104
LocationIreland
Business Address5960 Heisley Road,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.steris.com
Phone440 354 2600
CurrencyUSD - US Dollar

STERIS Plc Key Financial Ratios

STERIS Plc Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets5.4B6.6B11.5B10.8B11.1B11.6B
Other Current Liab281.2M335.7M379.5M395.0M478.1M502.0M
Net Debt830.9M1.4B2.8B2.8B3.2B3.3B
Retained Earnings1.6B1.9B2.0B1.9B2.1B2.2B
Accounts Payable149.3M157.0M225.7M279.6M251.7M264.3M
Cash319.6M220.5M348.3M208.4M207.0M126.3M
Net Receivables586.5M609.4M799.0M928.3M1.0B1.1B
Inventory248.3M315.1M575.0M695.5M674.5M708.3M
Other Current Assets54.4M66.8M156.6M179.3M979.3M1.0B
Total Liab2.0B2.7B4.9B4.7B4.7B5.0B
Total Current Assets1.2B1.2B1.9B2.0B2.9B3.0B
Short Term Debt19.8M22.8M179.3M95.0M117.2M123.0M
Intangible Assets565.5M898.4M3.3B3.0B2.1B2.2B
Common Stock2.0B2.0B4.7B4.5B4.5B4.8B
Other Liab250.6M454.5M1.0B693.7M797.7M837.6M
Other Assets51.6M52.7M70.7M78.1M1.00.95
Long Term Debt1.2B1.7B2.9B3.0B3.1B3.3B
Good Will2.4B3.0B4.4B3.9B4.1B4.3B
Net Tangible Assets472.3M854.9M(1.2B)2.2B2.5B2.7B
Long Term Debt Total1.2B1.7B2.9B3.0B3.5B1.8B

STERIS Plc Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue3.0B3.1B4.6B5.0B5.1B5.4B
Gross Profit1.3B1.3B2.0B2.2B2.2B2.3B
Operating Income341.1M323.3M425.6M268.2M836.1M877.9M
Ebit341.1M581.1M404.1M791.1M847.2M889.5M
Ebitda538.3M800.3M957.2M1.3B1.4B1.5B
Cost Of Revenue1.7B1.8B2.6B2.8B2.9B3.0B
Interest Expense40.3M37.2M89.6M109.6M144.4M151.6M
Income Before Tax498.7M517.5M314.5M157.3M702.8M738.0M
Net Income407.7M397.4M243.9M107.0M378.2M397.2M
Income Tax Expense90.9M120.7M71.6M51.5M149.5M157.0M
Research Development65.5M66.3M87.9M101.6M103.7M108.9M
Minority Interest12.8M(530K)1.0M1.2M(1.8M)(1.7M)
Tax Provision90.9M120.7M71.6M51.5M149.5M92.3M
Non Recurring31.0M673K(2.9M)491.1M564.7M592.9M
Interest Income38.3M6.3M6.3M110.8M11.0M10.5M
Net Interest Income(38.3M)(30.8M)(83.3M)(110.8M)(133.3M)(126.6M)

STERIS Plc Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(39.1M)3.8M(102.9M)(123.9M)(37.5M)(35.6M)
Change In Cash98.9M(99.1M)127.8M(140.0M)(1.3M)(1.3M)
Free Cash Flow376.0M450.4M397.2M395.0M612.9M643.6M
Depreciation(33.2M)(30.2M)553.1M552.9M565.2M593.5M
Other Non Cash Items232.5M273.8M86.6M495.2M814.2M854.9M
Capital Expenditures214.5M239.3M287.6M362.0M360.3M378.3M
End Period Cash Flow319.6M220.5M348.3M208.4M207.0M126.2M
Dividends Paid123.0M133.8M163.2M183.5M200.6M210.6M
Net Income407.8M396.9M242.9M105.8M380.1M399.1M
Investments(319.7M)(4.4M)(666.6M)(383.3M)(887.4M)(843.0M)
Net Borrowings(27.8M)471.7M372.2M150.7M173.3M147.8M
Change To Netincome35.3M54.5M223.3M340.9M392.0M411.6M

STERIS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining STERIS Plc's current stock value. Our valuation model uses many indicators to compare STERIS Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across STERIS Plc competition to find correlations between indicators driving STERIS Plc's intrinsic value. More Info.
STERIS plc is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.59  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for STERIS plc is roughly  1.70 . At present, STERIS Plc's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value STERIS Plc by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

STERIS plc Systematic Risk

STERIS Plc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. STERIS Plc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on STERIS plc correlated with the market. If Beta is less than 0 STERIS Plc generally moves in the opposite direction as compared to the market. If STERIS Plc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one STERIS plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of STERIS Plc is generally in the same direction as the market. If Beta > 1 STERIS Plc moves generally in the same direction as, but more than the movement of the benchmark.

STERIS Plc Thematic Clasifications

STERIS plc is part of several thematic ideas from Medical Equipment to Obamacare Repeal. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in STERIS Plc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various STERIS Plc's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of STERIS Plc growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.23

At present, STERIS Plc's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

STERIS Plc November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of STERIS Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of STERIS plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of STERIS plc based on widely used predictive technical indicators. In general, we focus on analyzing STERIS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build STERIS Plc's daily price indicators and compare them against related drivers.

Complementary Tools for STERIS Stock analysis

When running STERIS Plc's price analysis, check to measure STERIS Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STERIS Plc is operating at the current time. Most of STERIS Plc's value examination focuses on studying past and present price action to predict the probability of STERIS Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STERIS Plc's price. Additionally, you may evaluate how the addition of STERIS Plc to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bonds Directory
Find actively traded corporate debentures issued by US companies